American Association for the Study of Liver Disease (AASLD) – Industry Colloquium: Novel Targets and Therapies in Liver Disease
Event Date: January 19 - 20, 2018
Event Location: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Rockville, MD 20852
Diapharma is planning to attend the American Association for the Study of Liver Disease (AASLD) Industry Colloquium: Novel Targets and Therapies in Liver Disease meeting this year. Please click here to schedule a meeting with us or email us directly.
This conference will focus on therapeutic developments from the perspective of clinical and translational investigators and regulatory professionals. Participants will gain insight into novel therapies and the regulatory landscape for a variety of liver diseases with robust therapeutic pipelines. In addition, attendees will have opportunities to discuss the latest on biomarkers and the design of treatment studies for these diseases.
- Therapeutic developments from the perspective of clinical and translational investigators and regulatory professionals
- Novel therapies and the regulatory landscape for a variety of liver diseases with robust therapeutic pipelines
- The latest in biomarkers and the design of treatment studies for these diseases
- Session I: NASH
- Session II: Cholestatic Liver Diseases
- Session III: Portal HTN
- Session IV: Cirrhosis
- Session V: Hepatocellular Carcinoma
- Session VI: Hepatitis B
AASLD | Facebook | Twitter | LinkedIn | YouTube | Instagram | Bethesda North Marriott